Ann: 2019 AGM Audio Webcast, page-71

The SP slumped after initial surge. Maybe some were hoping for CE mark announcement? Maybe some insiders cashing in some holding after the AGM? There will be some who are pleased to get a chance at a few more.

The sales without that market are impressive anyway. When you get surgeons recommending a product to their colleagues and a continuous flow order process with hospitals, the product sells itself in the established markets.
The sales people are really there to open new territories and help customers set up that domino chain effect. The rest is just logistics.

If sales double each year without CE mark, then I wouldn't be surprised if they start tripling. It sounded like the company had people ready to head to customers in anticipation of CE mark and they are feeling frustrated over the delay.
I can see why it might disappoint some shareholders. That said, this has to be one of the best growth companies in the ASX in my view and Kudos to the PNV team!